In the fight against antimicrobial resistance there is an increasing need for global collaborative efforts for development and implementation of ideas unhindered by borders and socio-economic conditions. In keeping up with this necessity, the ARCH network has established strong partnerships to create a series of recommendations on reporting antimicrobial use and antimicrobial resistance rates to drive antibiotic stewardship, the “Bridge the Gap: Survey to Treat” White paper series. We are very happy to introduce our collaborators:
A JPIAMR Virtual Research Institute (VRI), the Global Antimicrobial resistance Platform for ONE Burden Estimates, GAP-ONE, network aims to create a virtual research environment able to:
- Involve all stakeholders into a Network that will provide an opportunity for participants from different disciplines to interconnect more fully and effectively.
- Identify all the data elements required to build a reliable tool for estimating resource waste due to AMR worldwide, not only in human health but also integrating veterinary and environmental data, within a One Health approach.
- Provide a framework to assess data quality.
- Devise a strategy for sharing currently available information.
Established under the IMI COMBACTE-MAGNET consortium of the New Drugs for Bad Bugs (ND4BB) programme, the epidemiology network (EPI-Net) is an unprecedented collaboration of experts in epidemiology and surveillance of healthcare-associated infections (HAIs) and antimicrobial resistance (AMR). EPI-Net engages representatives from major European Union financed projects and industry towards its objectives:
- Optimize surveillance of a resistance and healthcare associated infections
- Develop a consensus programme to contribute to the homogenization of the approach on current and future epidemiologic surveillance strategies in Europe
- Inform Public Health Action
- Support and guide R&D for new, effective antibiotics against antibiotic-resistant bacteria
A European Joint Action on AMR and Healthcare Associated Infections (EU-JAMRAI) initiative to check feasibility of setting up a European surveillance network of AMR in diseased animals (EARS-Vet). The specific objectives of the project include:
- Assess existing surveillance systems of AMR in animal pathogens in member states (MS) of Europe
- Identify the main gaps and appropriate strategies for AMR surveillance in diseased animals in Europe depending on MS specificities
- Assess the opportunities to combine MS surveillance systems into a pilot EU network for the surveillance of AMR in clinical animal isolates
- Identify laboratory and technical capacities in MS for potential establishment of a molecular based AMR national surveillance of relevant resistant pathogens
- Provide global and specific recommendations to EU to build a European network covering AMR surveillance in diseased animals, including interface with AMR surveillance in human medicine (SURVEILLANCE MANUAL)
Image credit: Uni Cape Town (Creative commons)